This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2020-2022.
Company Filing History:
Years Active: 2020-2022
Title: **David Duff Wisnoski: Innovator in Kinase Inhibition**
Introduction
David Duff Wisnoski, an accomplished inventor based in Collegeville, PA, has made significant strides in the realm of pharmaceutical innovations. With a portfolio that includes three patents, he is particularly known for his contributions to kinase inhibitors, compounds that play a crucial role in the treatment of various diseases.
Latest Patents
Among his most notable inventions is a patent focusing on heterocyclic amides as kinase inhibitors. This groundbreaking work details specific compounds that could enhance the effectiveness of targeted therapies, thereby opening new avenues for medical research and applications.
Career Highlights
Wisnoski currently works at GlaxoSmithKline Intellectual Property Development Limited, a leading organization in pharmaceutical research and development. His expertise and innovative spirit have helped the company push the boundaries of drug discovery and development.
Collaborations
Throughout his career, Wisnoski has collaborated with esteemed colleagues, including Niall Andrew Anderson and Deepak Bandyopadhyay. These partnerships have fostered an environment of shared knowledge and innovation, leading to the successful advancement of their projects.
Conclusion
David Duff Wisnoski stands out as a notable inventor in the field of kinase inhibitors. His work not only contributes to the scientific community but also aids in the development of novel therapeutic strategies that could improve patient outcomes in the future.